220 related articles for article (PubMed ID: 27586016)
1. The genotypic study of Mycobacterium tuberculosis complex resistant to isoniazid: Galicia, Spain (2008-2013).
Pérez Del Molino ML; Barbeito-Castiñeiras G; Mejuto B; Alonso P; Fernández A; González-Mediero G;
Eur J Clin Microbiol Infect Dis; 2016 Nov; 35(11):1795-1801. PubMed ID: 27586016
[TBL] [Abstract][Full Text] [Related]
2. [Defining of gene mutations and minimal inhibitory concentrations in isoniazid resistant Mycobacterium tuberculosis isolates].
Yıldırım E; Uzun M
Mikrobiyol Bul; 2017 Oct; 51(4):305-316. PubMed ID: 29153061
[TBL] [Abstract][Full Text] [Related]
3. [Description of Mycobacterium tuberculosis mutations conferring resistance to rifampicin and isoniazid detected by GenoType® MTBDRplus V.2 in Colombia].
Llerena C; Medina R
Biomedica; 2017 Jan; 37(1):28-33. PubMed ID: 28527245
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the GenoType MTBDRplus assay for detection of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates in central Ethiopia.
Bedewi Omer Z; Mekonnen Y; Worku A; Zewde A; Medhin G; Mohammed T; Pieper R; Ameni G
Int J Mycobacteriol; 2016 Dec; 5(4):475-481. PubMed ID: 27931690
[TBL] [Abstract][Full Text] [Related]
5. Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa.
Evans J; Stead MC; Nicol MP; Segal H
J Antimicrob Chemother; 2009 Jan; 63(1):11-6. PubMed ID: 18940875
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of GenoType MTBDRplus for the detection of multi-drug-resistant Mycobacterium tuberculosis strains].
Chikamatsu K; Mizuno K; Aono A; Yamada H; Sugamoto T; Nishiyama H; Mitarai S
Kekkaku; 2011 Jul; 86(7):697-702. PubMed ID: 21922778
[TBL] [Abstract][Full Text] [Related]
7. Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia.
Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
BMC Infect Dis; 2012 Feb; 12():37. PubMed ID: 22325147
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in clinical Mycobacterium tuberculosis complex clinical isolates].
Aslan G; Tezcan S; Emekdaş G
Mikrobiyol Bul; 2009 Apr; 43(2):217-26. PubMed ID: 19621606
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the GenoType® MTBDRplus assay and identification of a rare mutation for improving MDR-TB detection.
Jin J; Zhang Y; Fan X; Diao N; Shao L; Wang F; Hu P; Wang S; Weng X; Zhang W
Int J Tuberc Lung Dis; 2012 Apr; 16(4):521-6. PubMed ID: 22325117
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens.
Hillemann D; Rüsch-Gerdes S; Richter E
J Clin Microbiol; 2007 Aug; 45(8):2635-40. PubMed ID: 17537937
[TBL] [Abstract][Full Text] [Related]
11. Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Jagielski T; Bakuła Z; Roeske K; Kamiński M; Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J
J Antimicrob Chemother; 2014 Sep; 69(9):2369-75. PubMed ID: 24855126
[TBL] [Abstract][Full Text] [Related]
12. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China.
Jiao WW; Mokrousov I; Sun GZ; Li M; Liu JW; Narvskaya O; Shen AD
Chin Med J (Engl); 2007 May; 120(9):814-9. PubMed ID: 17531124
[TBL] [Abstract][Full Text] [Related]
13. Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis in Mongolia.
Narmandakh E; Tumenbayar O; Borolzoi T; Erkhembayar B; Boldoo T; Dambaa N; Burneebaatar B; Nymadawa N; Mitarai S; Jav S; Chiang CY
Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32312782
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
Pitso L; Potgieter S; Van der Spoel van Dijk A
S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
[TBL] [Abstract][Full Text] [Related]
15. Analysis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis isolates in Morocco using GenoType
Ennassiri W; Jaouhari S; Sabouni R; Cherki W; Charof R; Filali-Maltouf A; Lahlou O
J Glob Antimicrob Resist; 2018 Mar; 12():197-201. PubMed ID: 28993300
[TBL] [Abstract][Full Text] [Related]
16. Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
Valvatne H; Syre H; Kross M; Stavrum R; Ti T; Phyu S; Grewal HM
J Antimicrob Chemother; 2009 Oct; 64(4):694-701. PubMed ID: 19710078
[TBL] [Abstract][Full Text] [Related]
17. Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy.
Miotto P; Piana F; Penati V; Canducci F; Migliori GB; Cirillo DM
J Clin Microbiol; 2006 Jul; 44(7):2485-91. PubMed ID: 16825369
[TBL] [Abstract][Full Text] [Related]
18. Rifampicin and isoniazid resistance mutations in Mycobacterium tuberculosis strains isolated from patients in Kazakhstan.
Hillemann D; Kubica T; Agzamova R; Venera B; Rüsch-Gerdes S; Niemann S
Int J Tuberc Lung Dis; 2005 Oct; 9(10):1161-7. PubMed ID: 16229229
[TBL] [Abstract][Full Text] [Related]
19. Genotype MTBDR plus assay for molecular detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis.
Sharma S; Madan M; Agrawal C; Asthana AK
Indian J Pathol Microbiol; 2014; 57(3):423-6. PubMed ID: 25118735
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan.
Kozhamkulov U; Akhmetova A; Rakhimova S; Belova E; Alenova A; Bismilda V; Chingissova L; Ismailov S; Ramanculov E; Momynaliev K
Jpn J Infect Dis; 2011; 64(3):253-5. PubMed ID: 21617314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
